Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000609157 | SCV000291895 | benign | Autosomal recessive DOPA responsive dystonia | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000488317 | SCV000574870 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | TH: BS2 |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000609157 | SCV000745022 | benign | Autosomal recessive DOPA responsive dystonia | 2016-02-05 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001844099 | SCV000844486 | benign | not specified | 2024-08-20 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000609157 | SCV001262352 | benign | Autosomal recessive DOPA responsive dystonia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000488317 | SCV001898138 | benign | not provided | 2019-07-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001844099 | SCV002104131 | benign | not specified | 2022-02-18 | criteria provided, single submitter | clinical testing | Variant summary: TH c.16G>A (p.Ala6Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0042 in 246498 control chromosomes in the gnomAD database, including 7 homozygotes. The observed variant frequency is approximately 3.8 fold of the estimated maximal expected allele frequency for a pathogenic variant in TH causing Segawa Syndrome, Autosomal Recessive phenotype (0.0011), strongly suggesting that the variant is benign. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and a predominant consensus as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Breakthrough Genomics, |
RCV000488317 | SCV005321310 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000609157 | SCV000733021 | likely benign | Autosomal recessive DOPA responsive dystonia | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000609157 | SCV001457482 | benign | Autosomal recessive DOPA responsive dystonia | 2020-04-12 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003919990 | SCV004731120 | benign | TH-related disorder | 2020-05-22 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |